)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
AstraZeneca will start the withdrawal of marketing authorisation for the vaccine in Europe
During the quarter, the company launched 5 new products, of which 4 were launched in the US. A total of 21 products were launched during the year
The hospital group also claims that the ERP program improves the survival rate of the patients by approximately 2-3 per cent while enhancing patient outcomes through advanced techniques
The company reached a $1.1 billion settlement for CPAP machine lawsuits in US
AstraZeneca, facing a lawsuit in UK for alleged vaccine-related deaths and injuries, has acknowledged that its vaccine can cause Thrombosis with Thrombocytopenia Syndrome (TTS)
The researchers caution that more studies are needed to solidify this link
In financial year 2023, Indegene reported Rs 2,306.13 crore in revenue from operations with a profit of Rs 266 crore
It says top priority for new govt should be to strike balance between economic growth and environmental sustainability
The hospital claims that the costs of their treatments are significantly lower compared to traditional surgeries and modern medical treatments
The recent financial year witnessed Audi India retail 7,027 units, marking an overall growth of 33 per cent
For the fiscal year 2023-2024, Glenmark Life Sciences reported revenue from operations of Rs 2,283.2 crore, marking a growth of 5.6 per cent year-over-year (Y-o-Y)
This collaboration aims to expand their complementary nutraceutical portfolios in areas like metabolic care, hospital nutrition, general wellness, women's health, and child nutrition
26% volume growth seen in two-wheelers and 12% in passenger vehicles
A portable cold chain solution for last-mile vaccine delivery
The centre, which has a headcount of 700, will touch 1,000 by the end of CY24
A slowdown in demand from both domestic commercial vehicle manufacturers and subdued exports could limit revenue growth to a range of 6-8 per cent year-over-year
Tresa Motors designed the V0.2 with Indian road conditions in mind. The company says the truck is a durable and reliable solution for eco-friendly logistics, particularly e-commerce
Previously, Naoya Nishimura was the global Chief Research & Development Officer at Musashi
Founded in October 2021, the company's current manufacturing facility, located in Bangalore, holds a capacity to extract 5 tonnes of materials per day
Luxury Class cars also performed well, with a 152 per cent growth for BMW. Models like the 7 Series, X7, and the new XM played a key role in this achievement